Connor, Clark & Lunn Investment Management (CC&L)’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $826K | Sell |
|
|||||
|
2025
Q1 | $1.04M | Buy |
|
|||||
|
2024
Q4 | $2.42M | Buy |
|
|||||
|
2024
Q3 | $2.18M | Buy |
|
|||||
|
2024
Q2 | $2.02M | Buy |
|
|||||
|
2024
Q1 | $6.16M | Buy |
|
|||||
|
2023
Q4 | $2.35M | Buy |
|
|||||
|
2023
Q3 | $649K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $840K | Buy |
|
|||||
|
2022
Q2 | $651K | Buy |
|
|||||
|
2022
Q1 | $400K | Buy |
|
|||||
|
2021
Q4 | $639K | Buy |
|
|||||
|
2021
Q3 | $759K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $382K | Buy |
|
|||||
|
2019
Q4 | $322K | Buy |
|